Frontier Acquisition Corp. Class A FRON 深 滬
等待開盤 10-23 09:30:00 美东时间
10.17
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 10.17
- 總市值 2.99亿
- 52周最高 10.22
- 市盈率 靜 162.46
- 換手率 0.00%
- 52周最低 9.73
- 委 比 0.00%
- 總股本 2941.00万
- 歷史最高 10.78
- 量 比 0
- 振 幅 0.00%
- 歷史最低 9.61
- 每 手 1
- 風險率 0.00%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多OUTFRONT and AWS USHER IN A NEW ERA FOR OUT-OF-HOME ADVERTISING
Marks a Major Step Toward Digitizing and Automating OOH with AI-Enabled Workflows NEW YORK, Oct. 15, 2025 /PRNewswire/ -- In a significant industry development, OUTFRONT Media Inc. (NYSE: OU...
10-15 21:25
J. Front Retailing Co. Sees Revenue Growth Amid Market Adjustments
J FRONT RETAILING Co ( ($JP:3086) ) has issued an announcement. J. Front Retail...
10-15 15:22
J. FRONT RETAILING Co. Reports Mixed H1 Results
J FRONT RETAILING Co ( ($JFROF) ) has released its Q2 earnings. Here is a break...
10-15 11:52
Novo Nordisk submits haemophilia treatment application for review to FDA
Novo Nordisk (NVO) said that it has filed a biologic marketing application for Mim8 (denecimig) with the US FDA as a treatment to help prevent or lessen bleeding episodes in individuals with hemophili...
09-29 21:33
WWD Partners with OUTFRONT Media for Landmark National Hispanic Heritage Month Campaign
Celebrating Legendary Hispanic Designers in Times Square and Nationwide NEW YORK, Sept. 16, 2025 /PRNewswire/ -- Women's Wear Daily (WWD), the leading authority in fashion, beauty, and retai...
09-16 23:07
Jim Cramer: AppLovin Calls For Prudence, This Health Care Stock Is 'Pure Spec'
Jim Cramer doesn't recommend buying more AppLovin stock. "Let's take a little off the table just to be prudent," he said.
09-03 19:46
OUTFRONT Media Announces Quarterly Dividend
NEW YORK, Aug. 5, 2025 /PRNewswire/ -- OUTFRONT Media Inc. (NYSE: OUT) announced today that its board of directors has declared a quarterly cash dividend on the Company's common stock of $0....
08-06 04:06
Novo Nordisk's Alhemo Wins FDA Nod, Expanding Subcutaneous Option For Hemophilia Patients
FDA approves Novo Nordisk's Alhemo for hemophilia A and B without inhibitors, following strong Phase 3 results showing reduced bleeding episodes.
08-02 01:02
J. Front Retailing Revises June 2025 Revenue Report
J FRONT RETAILING Co ( ($JP:3086) ) has provided an update. J. Front Retailing ...
07-18 14:58
4D Molecular to layoff about 25% of workforce
4D Molecular Therapeutics (NASDAQ:FDMT) announced a significant workforce reduction of approximately 25% of its current and planned positions to streamline operations. The company is also speeding up ...
07-03 04:47
